Stablecoin Development Corp. (SDEV)
1.12
-0.02
(-1.75%)
USD |
NYAM |
Aug 24, 16:00
1.06
-0.06
(-5.36%)
After-Hours: 20:00
Stablecoin Development Enterprise Value : 49.54M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 49.54M |
| August 21, 2026 | 50.55M |
| August 20, 2026 | 49.54M |
| August 19, 2026 | 43.47M |
| August 18, 2026 | 39.91M |
| August 17, 2026 | 42.46M |
| August 14, 2026 | 44.99M |
| August 13, 2026 | 43.47M |
| August 12, 2026 | 43.47M |
| August 11, 2026 | 45.49M |
| August 10, 2026 | 44.48M |
| August 07, 2026 | 44.99M |
| August 06, 2026 | 45.49M |
| August 05, 2026 | 44.99M |
| August 04, 2026 | 41.45M |
| August 03, 2026 | 49.03M |
| July 31, 2026 | 51.06M |
| July 30, 2026 | 52.58M |
| July 29, 2026 | 50.05M |
| July 28, 2026 | 51.06M |
| July 27, 2026 | 49.54M |
| July 24, 2026 | 48.53M |
| July 23, 2026 | 50.05M |
| July 22, 2026 | 51.06M |
| July 21, 2026 | 53.59M |
| Date | Value |
|---|---|
| July 20, 2026 | 55.61M |
| July 17, 2026 | 56.12M |
| July 16, 2026 | 55.61M |
| July 15, 2026 | 57.63M |
| July 14, 2026 | 54.60M |
| July 13, 2026 | 52.07M |
| July 10, 2026 | 60.16M |
| July 09, 2026 | 61.68M |
| July 08, 2026 | 68.76M |
| July 07, 2026 | 56.12M |
| July 06, 2026 | 62.69M |
| July 02, 2026 | 61.68M |
| July 01, 2026 | 45.49M |
| June 30, 2026 | 46.00M |
| June 29, 2026 | 10.28M |
| June 26, 2026 | 11.89M |
| June 25, 2026 | 12.16M |
| June 24, 2026 | 11.89M |
| June 23, 2026 | 12.96M |
| June 22, 2026 | 12.69M |
| June 18, 2026 | 14.83M |
| June 17, 2026 | 14.03M |
| June 16, 2026 | 11.89M |
| June 15, 2026 | 11.09M |
| June 12, 2026 | 9.216M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.938B |
| Corcept Therapeutics, Inc. | 13.00B |
| Veru, Inc. | 21.05M |
| Johnson & Johnson | 685.82B |
| Eli Lilly & Co. | 1.220T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -41.07M |
| Revenue (Quarterly) | 2.206M |
| Total Expenses (Quarterly) | 43.28M |
| EPS Diluted (Quarterly) | -1.323 |
| Profit Margin (Quarterly) | -1.86K% |
| Earnings Yield | -66.12% |
| Normalized Earnings Yield | -188.62 |